SBI Mutual Fund trimmed its stake in Acutaas Chemicals Limited from 2.35% to 1.83%, selling 4,30,012 shares.
A research and development-driven manufacturer of specialty chemicals, Acutaas Chemical produces Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients for new chemical entities and innovative drug formulations. The company also supplies materials for agrochemicals and fine chemicals, serving global pharmaceutical and chemical industries. Its distinctive strength lies in vertically integrated manufacturing capabilities and specialized compound development through rigorous in-house research and technical expertise.
India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.
